185 related articles for article (PubMed ID: 35325065)
1. Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs.
Steffin DHM; Muhsen IN; Hill LC; Ramos CA; Ahmed N; Hegde M; Wang T; Wu M; Gottschalk S; Whittle SB; Lulla PD; Mamonkin M; Omer B; Rouce RH; Heczey A; Metelitsa LS; Grilley BJ; Robertson C; Torrano V; Lapteva N; Gee AP; Rooney CM; Brenner MK; Heslop HE
Blood; 2022 Jul; 140(1):16-24. PubMed ID: 35325065
[TBL] [Abstract][Full Text] [Related]
2. Decreased Mortality in 1-Year Survivors of Umbilical Cord Blood Transplant vs. Matched Related or Matched Unrelated Donor Transplant in Patients with Hematologic Malignancies.
Bohannon L; Tang H; Page K; Ren Y; Jung SH; Artica A; Britt A; Islam P; Siamakpour-Reihani S; Giri V; Lew M; Kelly M; Choi T; Gasparetto C; Long G; Lopez R; Rizzieri D; Sarantopoulos S; Chao N; Horwitz M; Sung A
Transplant Cell Ther; 2021 Aug; 27(8):669.e1-669.e8. PubMed ID: 33991725
[TBL] [Abstract][Full Text] [Related]
3. [Late infectious complications after high-dose therapy and autologous blood stem cell transplantation].
Metzner B; Grüneisl R; Gebauer W; Reschke D; Ost E; Müller TH; Reichert D; Rosien B; Del Valle F; Zirpel I; Kohse KP; Schunter F; Illiger HJ
Med Klin (Munich); 2002 Nov; 97(11):650-8. PubMed ID: 12434273
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial.
Mullane KM; Morrison VA; Camacho LH; Arvin A; McNeil SA; Durrand J; Campbell B; Su SC; Chan ISF; Parrino J; Kaplan SS; Popmihajlov Z; Annunziato PW;
Lancet Infect Dis; 2019 Sep; 19(9):1001-1012. PubMed ID: 31399378
[TBL] [Abstract][Full Text] [Related]
5. Current status of intensive end-of-life care in children with hematologic malignancy: a population-based study.
Yotani N; Shinjo D; Kato M; Matsumoto K; Fushimi K; Kizawa Y
BMC Palliat Care; 2021 Jun; 20(1):82. PubMed ID: 34098925
[TBL] [Abstract][Full Text] [Related]
6. Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study.
Hui D; Didwaniya N; Vidal M; Shin SH; Chisholm G; Roquemore J; Bruera E
Cancer; 2014 May; 120(10):1572-8. PubMed ID: 24549743
[TBL] [Abstract][Full Text] [Related]
7. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
8. Subsequent malignancies after allogeneic hematopoietic stem cell transplantation.
Gündüz M; Özen M; Şahin U; Toprak SK; Civriz Bozdağ S; Kurt Yüksel M; Arslan Ö; Özcan M; Demirer T; Beksaç M; İlhan O; Gürman G; Topçuoğlu P
Clin Transplant; 2017 Jul; 31(7):. PubMed ID: 28432802
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Subsequent Central Nervous System Tumors in Pediatric Allogeneic Hematopoietic Cell Transplant: A Study from the Center for International Blood and Marrow Transplant Research (CIBMTR).
Gabriel M; Shaw BE; Brazauskas R; Chen M; Margolis DA; Sengelov H; Dahlberg A; Ahmed IA; Delgado D; Lazarus HM; Gibson B; Myers KC; Kamble RT; Abdel-Mageed A; Li CK; Flowers MED; Battiwalla M; Savani BN; Majhail N; Shaw PJ
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1320-1326. PubMed ID: 28411175
[TBL] [Abstract][Full Text] [Related]
10. Indwelling Pleural Catheters for Patients with Hematologic Malignancies. A 14-Year, Single-Center Experience.
Faiz SA; Pathania P; Song J; Li L; Balachandran DD; Ost DE; Morice RC; Shannon VR; Bashoura L; Eapen GA; Jimenez CA
Ann Am Thorac Soc; 2017 Jun; 14(6):976-985. PubMed ID: 28326798
[TBL] [Abstract][Full Text] [Related]
11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
12. Outcome of Haploidentical Peripheral Blood Allografts Using Post-Transplantation Cyclophosphamide Compared to Matched Sibling and Unrelated Donor Bone Marrow Allografts in Pediatric Patients with Hematologic Malignancies: A Single-Center Analysis.
Srinivasan A; Raffa E; Wall DA; Schechter T; Ali M; Chopra Y; Kung R; Chiang KY; Krueger J
Transplant Cell Ther; 2022 Mar; 28(3):158.e1-158.e9. PubMed ID: 34838785
[TBL] [Abstract][Full Text] [Related]
13. Retroviral and Lentiviral Safety Analysis of Gene-Modified T Cell Products and Infused HIV and Oncology Patients.
Marcucci KT; Jadlowsky JK; Hwang WT; Suhoski-Davis M; Gonzalez VE; Kulikovskaya I; Gupta M; Lacey SF; Plesa G; Chew A; Melenhorst JJ; Levine BL; June CH
Mol Ther; 2018 Jan; 26(1):269-279. PubMed ID: 29203150
[TBL] [Abstract][Full Text] [Related]
14. The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic malignancies.
Shaw JL; Nielson CM; Park JK; Marongiu A; Soff GA
Eur J Haematol; 2021 May; 106(5):662-672. PubMed ID: 33544940
[TBL] [Abstract][Full Text] [Related]
15. [Safety and effectiveness of tumor-ablative chemotherapy combined with low intensity modified conditioning regimen for 30 patients with hematologic malignancies receiving allogeneic hematopoietic stem cell transplantation].
Luo RM; Da WM; Hu B; Si YJ; Zhang XM; Du ZL; Liu QH; Wang Y; Yue Y; Chen W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1047-52. PubMed ID: 25130826
[TBL] [Abstract][Full Text] [Related]
16. Comparison of symptom burden among patients referred to palliative care with hematologic malignancies versus those with solid tumors.
Fadul NA; El Osta B; Dalal S; Poulter VA; Bruera E
J Palliat Med; 2008 Apr; 11(3):422-7. PubMed ID: 18363482
[TBL] [Abstract][Full Text] [Related]
17. Pediatric solid tumors and second malignancies: characteristics and survival outcomes.
Vasudevan V; Cheung MC; Yang R; Zhuge Y; Fischer AC; Koniaris LG; Sola JE
J Surg Res; 2010 May; 160(2):184-9. PubMed ID: 19765728
[TBL] [Abstract][Full Text] [Related]
18. Disparities in the Outcomes of Acute Pulmonary Embolism in Hospitalized Patients with Hematologic Malignancy and Solid Tumor.
Hou J; Qiu Z; Yu L; Wen S; Zheng L
Int Heart J; 2023; 64(3):432-441. PubMed ID: 37258119
[TBL] [Abstract][Full Text] [Related]
19. Modified busulfan and cyclophosphamide conditioning regimen for allogeneic hematopoietic stem cell transplantation in the treatment of patients with hematologic malignancies.
Zhao XF; Mao XF; Wan DM; Liu W
Transplant Proc; 2014 Jun; 46(5):1531-5. PubMed ID: 24935325
[TBL] [Abstract][Full Text] [Related]
20. Immune Modulation in Hematologic Malignancies.
Dhodapkar MV; Dhodapkar KM
Semin Oncol; 2015 Aug; 42(4):617-25. PubMed ID: 26320065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
